Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HILPDA | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
mRNA | PSMB6 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
mRNA | GRM2 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | BCL11A | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
mRNA | PIAS2 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
mRNA | CSRNP3 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | GOLGA8Q | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | TTC3 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
mRNA | DNAI2 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | GOLGA8N | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |